STOCK TITAN

[SCHEDULE 13D/A] NeueHealth, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

NEA groups amended prior Schedule 13D to report financing and a completed merger. On October 2, 2025 the NEA lender groups provided incremental loans totaling $37.3M under an amended credit agreement and received up to 1,116,765 Warrants issued at an exercise price of $0.01. Individual NEA lenders funded borrowings on October 2, 2025 of $4,141,141.68, $6,211,712.53, $12,423,425.05 and $14,493,995.90, respectively, and received corresponding warrant allotments. The Reporting Persons net‑exercised those Warrants immediately prior to closing based on a fair market value of $6.75 per share and contributed their equity into a parent vehicle in connection with a merger, after which all outstanding public common shares were cancelled and certain dissenting shares were converted into $7.33 cash per share. Following the Merger, the Reporting Persons state they do not beneficially own any common stock and have ceased to own five percent or more of the class. The filing notes intent to delist and deregister the common stock and to file Form 15 to terminate reporting obligations.

I gruppi NEA hanno modificato in precedenza Schedule 13D per riferire finanziamenti e una fusione completata. Il 2 ottobre 2025 i gruppi di prestatori NEA hanno fornito prestiti incrementali per un totale di $37.3M secondo un accordo di credito modificato e hanno ricevuto fino a 1.116.765 warrant emessi a un prezzo di esercizio di $0.01. I singoli prestatori NEA hanno finanziato i prestiti il 2 ottobre 2025 per $4,141,141.68, $6,211,712.53, $12,423,425.05 e $14,493,995.90, rispettivamente, e hanno ricevuto le corrispondenti assegnazioni di warrant. I Reporting Persons hanno esercitato quei Warrants in modo netto immediatamente prima della chiusura basandosi su un valore equo di mercato di $6.75 per azione e hanno versato il proprio capitale in una società madre in relazione a una fusione, dopo di che tutte le azioni ordinarie pubbliche in circolazione sono state cancellate e alcune azioni dissenzienti sono state convertite in $7.33 in contanti per azione. Dopo la fusione, i Reporting Persons dichiarano di non detenere più azioni ordinarie e non possedere più il cinque percento o più della classe. La dichiarazione riporta l’intenzione di delistare e deregistrare le azioni ordinarie e di presentare il modulo Form 15 per terminare gli obblighi di segnalazione.

Los grupos prestamistas de NEA enmendaron previamente el Schedule 13D para reportar financiamiento y una fusión completada. El 2 de octubre de 2025 los grupos de prestamistas NEA proporcionaron préstamos incrementales por un total de $37.3M bajo un acuerdo de crédito enmendado y recibieron hasta 1,116,765 Warrants emitidos a un precio de ejercicio de $0.01. Los prestamistas NEA individuales financieron préstamos el 2 de octubre de 2025 por $4,141,141.68, $6,211,712.53, $12,423,425.05 y $14,493,995.90, respectivamente, y recibieron las correspondientes asignaciones de warrants. Los Reporting Persons netearon esos Warrants inmediatamente antes del cierre basándose en un valor de mercado razonable de $6.75 por acción y aportaron su capital a una entidad matriz en relación con una fusión, después de lo cual todas las acciones comunes públicas en circulación fueron canceladas y ciertas acciones disidentes fueron convertidas en $7.33 por acción en efectivo. Después de la fusión, los Reporting Persons declaran que no poseen acciones comunes y han dejado de poseer el cinco por ciento o más de la clase. El reporte señala la intención de eliminar la cotización y deregistrar las acciones comunes y presentar el Formulario 15 para terminar las obligaciones de reporte.

NEA 그룹은 이전 Schedule 13D를 수정하여 재무 조달 및 완료된 합병을 보고합니다. 2025년 10월 2일에 NEA 대주단 그룹은 수정된 신용계약에 따라 총 $37.3M의 증분 대출을 제공했고 1,116,765 워런트를 행사 가격 $0.01로 받았습니다. 개별 NEA 대주단은 2025년 10월 2일$4,141,141.68, $6,211,712.53, $12,423,425.05$14,493,995.90의 차입금을 조달했고, 해당하는 워런트 배분도 받았습니다. 보고 당사자들은 공정가치가 주당 $6.75일 때 그 워런트를 순수익으로 행사했고, 합병과 관련된 모회사에 자본을 출자한 뒤 모든 미상장 공모주가 취소되었고 일부 반대 주식은 주당 $7.33의 현금으로 전환되었습니다. 합병 후 보고 당사자들은 더 이상 보통주를 보유하지 않으며 해당 계층의 5% 이상을 보유하지 않는다고 밝혔습니다. 공시는 보통주의 상장폐지 및 등록 해지 의향과 보고 의무를 종료하기 위한 Form 15 제출을 명시합니다.

Les groupes NEA ont modifié les Schedule 13D antérieurs pour rendre compte du financement et d'une fusion réalisée. Le 2 octobre 2025, les groupes prêteurs NEA ont accordé des prêts supplémentaires totalisant $37.3M dans le cadre d'un accord de crédit modifié et ont reçu jusqu'à 1 116 765 warrants émis à un prix d'exercice de $0.01. Les prêteurs NEA individuels ont financé des emprunts le 2 octobre 2025 pour $4,141,141.68, $6,211,712.53, $12,423,425.05 et $14,493,995.90, respectivement, et ont reçu les attributions de warrants correspondantes. Les Reporting Persons ont exercé ces warrants nettes juste avant la clôture en se basant sur une valeur de marché équitable de $6.75 par action et ont apporté leurs capitaux dans une société mère dans le cadre d'une fusion, après quoi toutes les actions ordinaires publiques en circulation ont été annulées et certaines actions dissidentes ont été converties en $7.33 en espèces par action. Suite à la fusion, les Reporting Persons indiquent ne posséder aucune action ordinaire et ne détenir plus 5% ou plus de la classe. Le dépôt mentionne l'intention de retirer la cotation et le deregistrer des actions ordinaires et de déposer le formulaire Form 15 pour mettre fin aux obligations de rapport.

NEA-Gruppen haben zuvor Schedule 13D geändert, um Finanzierung und eine abgeschlossene Fusion zu melden. Am 2. Oktober 2025 stellten die NEA-Darlehensgruppen im Rahmen eines geänderten Kreditvertrags zusätzliche Darlehen in Höhe von $37.3M bereit und erhielten bis zu 1.116.765 Warrants mit einem Ausübungspreis von $0.01. Einzelne NEA-Darlehensgeber finanzierten am 2. Oktober 2025 Ausleihen in Höhe von $4,141,141.68, $6,211,712.53, $12,423,425.05 und $14,493,995.90 und erhielten entsprechende Warrants-Zuteilungen. Die Berichtspersonen übten diese Warrants im Nettoeinkauf unmittelbar vor dem Abschluss basierend auf einem fairen Marktwert von $6.75 pro Aktie aus und trugen ihr Kapital in eine Muttergesellschaft im Zusammenhang mit einer Fusion ein, woraufhin alle ausstehenden öffentlichen Stammaktien storniert wurden und bestimmte dissenting shares in $7.33 pro Aktie in Bar umgewandelt wurden. Nach der Fusion geben die Berichtspersonen an, keine Stammaktien mehr zu halten und nicht mehr 5 Prozent oder mehr der Klasse zu besitzen. Die Einreichung weist auf die Absicht hin, die Börsennotierung zu löschen und zu deregistrieren sowie Form 15 einzureichen, um die Meldepflichten zu beenden.

الجماعات التابعة لـ NEA عدّلت مجموعات Schedule 13D السابقة للإبلاغ عن التمويل واندماج مكتمل. في 2 أكتوبر 2025 قدّمت جماعات المقرضين من NEA قروضًا إضافية بإجمالى $37.3M بموجب اتفاق ائتماني معدّل وتلقت حتى 1,116,765 مناصرة Warrants صدرت بسعر ممارسة $0.01. وقام المقرضون الفرديون من NEA بتمويل القروض في 2 أكتوبر 2025 بمبالغ $4,141,141.68، $6,211,712.53، $12,423,425.05 و $14,493,995.90، على التوالي، وتلقوا تخصيصات Warrants المقابلة. كما قام الأشخاص المبلِّغون بتمرين هذه warrants صافيًا فور الإغلاق استنادًا إلى قيمة سوقية عادلة قدرها $6.75 للسهم، وقدموا رؤوس أموالهم إلى كيان أم في إطار دمج، وبعدها أُلغيت جميع الأسهم العادية العامة القائمة وجرى تحويل بعض الأسهم المعترضة إلى $7.33 نقدًا للسهم. بعد الدمج، يذكر الأشخاص المبلِّغون أنهم لا يمتلكون أي أسهم عادية ولم يعودوا يملكون 5% أو أكثر من الصنف. تشير الوثيقة إلى نية فَكّ إدراج الأسهم وتسجيلها وإلى تقديم النموذج Form 15 لإنهاء الالتزامات بالتقرير.

NEA 组在先前的 Schedule 13D 上修订以报告融资与完成的并购。2025年10月2日,NEA 贷款人集团按照经修订的信贷协议提供总额为 $37.3M 的增量贷款,并收到至多 1,116,765 份认股权证,行使价格为 $0.01。单独的 NEA 贷款人于 2025年10月2日 分别融资了 $4,141,141.68$6,211,712.53$12,423,425.05$14,493,995.90,并收到相应的认股权证分配。在完成交易前,申报人按每股 $6.75 的公允市场价净行使了这些认股权证,并将他们的资本投入到一个与并购相关的母公司实体中,随后所有在外公开流通的普通股被取消,部分持异议的股票按每股 $7.33 的现金转换。并购完成后,申报人表示不再持有任何普通股,且不再持有该类别的 5% 及以上股份。该披露还指出有意撤销普通股的上市与注册,并提交 Form 15 以终止披露义务。

Positive
  • NEA provided incremental financing of $37.3M to support the Issuer
  • NEA received up to 1,116,765 Warrants enabling equity participation at an exercise price of $0.01
  • Warrants were net‑exercised at $6.75 per share, converting credit exposure into equity value
  • Reporting Persons completed a merger that consolidated ownership into a private parent vehicle
Negative
  • Reporting Persons ceased to own ≥5% of common stock as of October 2, 2025
  • Issuer's common stock was delisted and deregistration was initiated, reducing public liquidity and reporting transparency
  • Public shareholders received a cash-out option of $7.33 per dissenting share, limiting future public upside

Insights

NEA converted credit exposure into equity economics and partnership interests.

The NEA lenders provided $37.3M of incremental loans under an amended credit agreement and received up to 1,116,765 Warrants exercisable at $0.01, which were net‑exercised at a fair market value of $6.75 per share immediately before closing. Those equity interests were contributed into a parent partnership in exchange for limited partnership interests, converting direct public equity into private partnership economics.

This structure reduces NEA's public share ownership while preserving economic upside through partnership interests; risks include minority economics in the new parent and the loss of public liquidity. Monitor termination or amendment of the Amended Credit Agreement and any lockups or transfer restrictions over the next 6–12 months.

Transaction completed a take‑private merger with cash-out terms for public holders.

The Merger caused cancellation of outstanding public common stock and conversion of dissenting shares into $7.33 per share cash. The Issuer requested NYSE suspension and filing of Form 25, and intends to file Form 15 to cease reporting under the Exchange Act.

Consequences include delisting, reduced public disclosure and loss of a public float; this materially changes investor access to financial information. Watch for the effective filing of Form 15 and any post‑closing disclosures by the new private parent in the next 30–90 days.

I gruppi NEA hanno modificato in precedenza Schedule 13D per riferire finanziamenti e una fusione completata. Il 2 ottobre 2025 i gruppi di prestatori NEA hanno fornito prestiti incrementali per un totale di $37.3M secondo un accordo di credito modificato e hanno ricevuto fino a 1.116.765 warrant emessi a un prezzo di esercizio di $0.01. I singoli prestatori NEA hanno finanziato i prestiti il 2 ottobre 2025 per $4,141,141.68, $6,211,712.53, $12,423,425.05 e $14,493,995.90, rispettivamente, e hanno ricevuto le corrispondenti assegnazioni di warrant. I Reporting Persons hanno esercitato quei Warrants in modo netto immediatamente prima della chiusura basandosi su un valore equo di mercato di $6.75 per azione e hanno versato il proprio capitale in una società madre in relazione a una fusione, dopo di che tutte le azioni ordinarie pubbliche in circolazione sono state cancellate e alcune azioni dissenzienti sono state convertite in $7.33 in contanti per azione. Dopo la fusione, i Reporting Persons dichiarano di non detenere più azioni ordinarie e non possedere più il cinque percento o più della classe. La dichiarazione riporta l’intenzione di delistare e deregistrare le azioni ordinarie e di presentare il modulo Form 15 per terminare gli obblighi di segnalazione.

Los grupos prestamistas de NEA enmendaron previamente el Schedule 13D para reportar financiamiento y una fusión completada. El 2 de octubre de 2025 los grupos de prestamistas NEA proporcionaron préstamos incrementales por un total de $37.3M bajo un acuerdo de crédito enmendado y recibieron hasta 1,116,765 Warrants emitidos a un precio de ejercicio de $0.01. Los prestamistas NEA individuales financieron préstamos el 2 de octubre de 2025 por $4,141,141.68, $6,211,712.53, $12,423,425.05 y $14,493,995.90, respectivamente, y recibieron las correspondientes asignaciones de warrants. Los Reporting Persons netearon esos Warrants inmediatamente antes del cierre basándose en un valor de mercado razonable de $6.75 por acción y aportaron su capital a una entidad matriz en relación con una fusión, después de lo cual todas las acciones comunes públicas en circulación fueron canceladas y ciertas acciones disidentes fueron convertidas en $7.33 por acción en efectivo. Después de la fusión, los Reporting Persons declaran que no poseen acciones comunes y han dejado de poseer el cinco por ciento o más de la clase. El reporte señala la intención de eliminar la cotización y deregistrar las acciones comunes y presentar el Formulario 15 para terminar las obligaciones de reporte.

NEA 그룹은 이전 Schedule 13D를 수정하여 재무 조달 및 완료된 합병을 보고합니다. 2025년 10월 2일에 NEA 대주단 그룹은 수정된 신용계약에 따라 총 $37.3M의 증분 대출을 제공했고 1,116,765 워런트를 행사 가격 $0.01로 받았습니다. 개별 NEA 대주단은 2025년 10월 2일$4,141,141.68, $6,211,712.53, $12,423,425.05$14,493,995.90의 차입금을 조달했고, 해당하는 워런트 배분도 받았습니다. 보고 당사자들은 공정가치가 주당 $6.75일 때 그 워런트를 순수익으로 행사했고, 합병과 관련된 모회사에 자본을 출자한 뒤 모든 미상장 공모주가 취소되었고 일부 반대 주식은 주당 $7.33의 현금으로 전환되었습니다. 합병 후 보고 당사자들은 더 이상 보통주를 보유하지 않으며 해당 계층의 5% 이상을 보유하지 않는다고 밝혔습니다. 공시는 보통주의 상장폐지 및 등록 해지 의향과 보고 의무를 종료하기 위한 Form 15 제출을 명시합니다.

Les groupes NEA ont modifié les Schedule 13D antérieurs pour rendre compte du financement et d'une fusion réalisée. Le 2 octobre 2025, les groupes prêteurs NEA ont accordé des prêts supplémentaires totalisant $37.3M dans le cadre d'un accord de crédit modifié et ont reçu jusqu'à 1 116 765 warrants émis à un prix d'exercice de $0.01. Les prêteurs NEA individuels ont financé des emprunts le 2 octobre 2025 pour $4,141,141.68, $6,211,712.53, $12,423,425.05 et $14,493,995.90, respectivement, et ont reçu les attributions de warrants correspondantes. Les Reporting Persons ont exercé ces warrants nettes juste avant la clôture en se basant sur une valeur de marché équitable de $6.75 par action et ont apporté leurs capitaux dans une société mère dans le cadre d'une fusion, après quoi toutes les actions ordinaires publiques en circulation ont été annulées et certaines actions dissidentes ont été converties en $7.33 en espèces par action. Suite à la fusion, les Reporting Persons indiquent ne posséder aucune action ordinaire et ne détenir plus 5% ou plus de la classe. Le dépôt mentionne l'intention de retirer la cotation et le deregistrer des actions ordinaires et de déposer le formulaire Form 15 pour mettre fin aux obligations de rapport.

NEA-Gruppen haben zuvor Schedule 13D geändert, um Finanzierung und eine abgeschlossene Fusion zu melden. Am 2. Oktober 2025 stellten die NEA-Darlehensgruppen im Rahmen eines geänderten Kreditvertrags zusätzliche Darlehen in Höhe von $37.3M bereit und erhielten bis zu 1.116.765 Warrants mit einem Ausübungspreis von $0.01. Einzelne NEA-Darlehensgeber finanzierten am 2. Oktober 2025 Ausleihen in Höhe von $4,141,141.68, $6,211,712.53, $12,423,425.05 und $14,493,995.90 und erhielten entsprechende Warrants-Zuteilungen. Die Berichtspersonen übten diese Warrants im Nettoeinkauf unmittelbar vor dem Abschluss basierend auf einem fairen Marktwert von $6.75 pro Aktie aus und trugen ihr Kapital in eine Muttergesellschaft im Zusammenhang mit einer Fusion ein, woraufhin alle ausstehenden öffentlichen Stammaktien storniert wurden und bestimmte dissenting shares in $7.33 pro Aktie in Bar umgewandelt wurden. Nach der Fusion geben die Berichtspersonen an, keine Stammaktien mehr zu halten und nicht mehr 5 Prozent oder mehr der Klasse zu besitzen. Die Einreichung weist auf die Absicht hin, die Börsennotierung zu löschen und zu deregistrieren sowie Form 15 einzureichen, um die Meldepflichten zu beenden.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


New Enterprise Associates 15, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA Partners 15, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA 15 Opportunity Fund, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA Partners 15-OF, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA 15 GP, LLC
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
New Enterprise Associates 16, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA Partners 16, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA 16 GP, LLC
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
New Enterprise Associates 17, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA Partners 17, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA 17 GP, LLC
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA 18 Venture Growth Equity, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA Partners 18 VGE, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA 18 VGE GP, LLC
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA BH SPV, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA BH SPV II, L.P.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
NEA BH SPV GP, LLC
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi, Managing Partner and Co-Chief Executive Officer
Date:10/06/2025
Forest Baskett
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Forest Baskett
Date:10/06/2025
Ali Behbahani
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Ali Behbahani
Date:10/06/2025
Carmen Chang
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Carmen Chang
Date:10/06/2025
Anthony A. Florence, Jr.
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Anthony A. Florence, Jr.
Date:10/06/2025
Mohamad H. Makhzoumi
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Mohamad H. Makhzoumi
Date:10/06/2025
Edward T. Mathers
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Edward T. Mathers
Date:10/06/2025
Scott D. Sandell
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Scott D. Sandell
Date:10/06/2025
Paul Walker
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Paul Walker
Date:10/06/2025
Rick Yang
Signature:/s/ Stephanie Brecher
Name/Title:Stephanie Brecher as attorney-in-fact for Rick Yang
Date:10/06/2025
Comments accompanying signature:
This Amendment No. 9 to Schedule 13D was executed by Stephanie Brecher on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2.

FAQ

What financing did NEA provide to NeueHealth (NEUE)?

NEA lenders provided incremental loans totaling $37.3M under an amended credit agreement, with individual borrowings funded on October 2, 2025.

How many warrants did NEA receive and at what price?

NEA received up to 1,116,765 Warrants issued at an exercise price of $0.01 per share.

What happened to NEA's public common stock holdings after the Merger?

NEA net‑exercised Warrants and contributed resulting shares into the parent structure; after the Merger they report owning no common stock and ceased to own ≥5% of the class as of October 2, 2025.

What cash consideration was paid to dissenting shareholders?

Dissenting Shares were converted into the right to receive $7.33 in cash per share, less applicable withholding taxes.

Will NeueHealth remain listed and report publicly?

The Issuer requested NYSE suspension and removal, filed Form 25 to delist, and intends to file Form 15 to deregister and suspend reporting under the Exchange Act.
NeueHealth Inc

NYSE:NEUE

NEUE Rankings

NEUE Latest News

NEUE Latest SEC Filings

NEUE Stock Data

60.94M
7.28M
9.45%
58.37%
0.14%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
DORAL